Chemotherapy: antibiotics targeting protein synthesis

44 Chemotherapy


antibiotics targeting protein synthesis





Agents affecting protein synthesis


Bacterial protein synthesis occurs on ribosomes, which are made up of two subunits (50S and 30S in bacteria). Messenger RNA (mRNA) is the template for protein synthesis and transfer RNA (tRNA) brings each amino acid to the ribosome for assembly into the protein molecule (Fig. 3.44.1). A number of different classes of drug selectively target different elements of this process. These agents are bacteriostatic, with the exception of aminoglycosides and oxazolidinones.






Aminoglycosides


These agents selectively enter aerobic bacteria by an oxygen-dependent transport system. Hence, anaerobic bacteria have a natural resistance. Aminoglycosides bind to the 30S subunit in an irreversible manner, which leads to misreading of mRNA. These agents have a broad spectrum of activity, with the exception of anerobes, streptococci and pnenumococci. Their bactericidal activity can be enhanced when coadministered with penicillins as damage to the cell wall facilitates penetration of aminoglycosides into the bacteria. Resistance to these drugs is an increasing problem. Aminoglycosides have poor oral bioavailability and are administered i.v. Gentamicin is the aminoglycoside most commonly used to treat infections by Gram-negative bacteria, although tobramycin is preferred for infection with Pseudomonas aeruginosa. Streptomycin is used in the treatment of Mycobacterium tuberculosis. The side-effects of this drug class limit its utility. Adverse events include ototoxicity: a progressive damage to the sensory cells of the cochlea and vestibular organ of the ear resulting in ataxia, loss of balance, vertigo and deafness. Damage to the kidney renal tubules leads to nephrotoxicity, which will impair plasma clearance of the antibiotic. A rare but serious toxic condition is paralysis of skeletal muscle caused by inhibition of Ca2+ uptake into cholinergic nerves and inhibition of release of acetylcholine.


Chloramphenicol is bacteriostatic and binds to the 50S subunit, inhibiting peptidyl transferase activity. This prevents transpeptidation of the growing amino acid chain on the P site to the newly arrived peptidyl tRNA on the A site. This antibiotic has a broad spectrum of activity; however, susceptibility to resistance is high because of expression of ‘chloramphenicol acetyltransferase’. The ability of chloramphenicol to cause aplastic anaemia (decreased production of red blood cells) when administered systemically limits its usefulness and it is reserved for life-threatening infections.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 18, 2016 | Posted by in PHARMACY | Comments Off on Chemotherapy: antibiotics targeting protein synthesis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access